N,N-Dimethyl-2′-O-methyladenosine

• UNSPSC Description:

  N,N-Dimethyl-2′-O-methyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/n-n-dimethyl-2-o-methyladenosine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O[C@H]1[C@@H](OC)[C@H](N2C(N=CN=C3N(C)C)=C3N=C2)O[C@@H]1CO

• Molecular Weight:

  309.32

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  30891-53-3